| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 27, 2026 | ±2.1% | +0.3% | over-priced |
| October 28, 2025 | ±2.1% | -6.1% | under-priced |
| July 28, 2025 | ±1.3% | -0.8% | over-priced |
| April 28, 2025 | ±3.6% | +0.4% | over-priced |
| July 22, 2024 | ±1.2% | +0.8% | over-priced |
| April 24, 2024 | ±1.5% | -1.0% | over-priced |
| October 26, 2023 | ±2.9% | -0.8% | over-priced |
| July 27, 2023 | ±1.8% | -1.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.06 | $1.9B | $427M |
| Q4 FY2025 | $0.59 | $1.6B | $268M |
| Q3 FY2025 | $0.68 | $1.6B | $229M |
| Q2 FY2025 | $0.78 | $1.3B | $234M |
Brown & Brown, Inc. (BRO) reports in 114 days, with the next report estimated for October 5, 2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 1.5% on average — the market has systematically over-priced BRO's earnings risk. Fundamentals into the print: EPS down 7.8% year-over-year, revenue up 35.4%. QuantLogix's live 5-factor engine currently reads BRO as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →